Impact of paclitaxel, cisplatin, and gemcitabine as first-line chemotherapy in cisplatin-fit and -unfit patients with advanced/metastatic urothelial carcinoma

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Impact of paclitaxel, cisplatin, and gemcitabine as first-line chemotherapy in cisplatin-fit and -unfit patients with advanced/metastatic urothelial carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences